TCM
ALAB icon

Triumph Capital Management’s Astera Labs ALAB Stock Holding History

Triumph Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$483 Buy
+1
New +$265 ﹤0.01% 1734

Other funds holding ALAB

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SSA
Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
TEC
Tensor Edge Capital Weston, Massachusetts $1.51B AUM
MLCM
M & L Capital Management London, United Kingdom $370M AUM 165.61% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Triumph Capital Management's ALAB Position: Q2 2026 in Review

Triumph Capital Management opened a new position in Astera Labs (ALAB) in Q2 2026: 1 share worth $483. The stake represents ﹤0.01% of the portfolio and ranks #1734 among its holdings.

161 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Triumph Capital Management held 1 share of Astera Labs worth $483 as of Q2 2026.
  • Astera Labs was a new Triumph Capital Management position in Q2 2026.
  • Astera Labs made up ﹤0.01% of Triumph Capital Management's portfolio in Q2 2026, its #1734 holding.
  • 161 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.